Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	actin filament severing	FLII MYH9 VILL	7.23e-06	18	44	3	GO:0051014
GeneOntologyBiologicalProcess	muscle structure development	CFH WNT5B FLII MYH9 ACVR1 KAT5 PDLIM3 NEK5 CFHR4 SCN8A	1.01e-05	858	44	10	GO:0061061
GeneOntologyBiologicalProcess	activation of membrane attack complex	CFH CFHR4	6.64e-05	6	44	2	GO:0001905
GeneOntologyBiologicalProcess	gastrulation	WNT5B TRIM15 MYH9 ACVR1 MEGF8	8.58e-05	212	44	5	GO:0007369
GeneOntologyBiologicalProcess	regulation of complement activation, alternative pathway	CFH CFHR4	9.28e-05	7	44	2	GO:0030451
GeneOntologyBiologicalProcess	muscle cell differentiation	CFH WNT5B FLII MYH9 ACVR1 NEK5 CFHR4	1.21e-04	531	44	7	GO:0042692
GeneOntologyBiologicalProcess	actin filament capping	FLII MYH9 VILL	1.29e-04	46	44	3	GO:0051693
GeneOntologyBiologicalProcess	immune complex clearance	CFH CFHR4	1.59e-04	9	44	2	GO:0002434
GeneOntologyBiologicalProcess	monocyte aggregation	CFH CFHR4	1.59e-04	9	44	2	GO:0070487
GeneOntologyBiologicalProcess	negative regulation of actin filament depolymerization	FLII MYH9 VILL	1.86e-04	52	44	3	GO:0030835
GeneOntologyBiologicalProcess	retinal pigment epithelium development	CFH CFHR4	1.98e-04	10	44	2	GO:0003406
GeneOntologyBiologicalProcess	negative regulation of DNA recombination	MSH3 KAT5 HELB	2.20e-04	55	44	3	GO:0045910
GeneOntologyBiologicalProcess	blood vessel morphogenesis	CFH MYH9 ACVR1 MEGF8 TNFSF12 ADAMTS9 NOTCH3 CFHR4	2.92e-04	817	44	8	GO:0048514
GeneOntologyBiologicalProcess	regulation of actin filament depolymerization	FLII MYH9 VILL	2.99e-04	61	44	3	GO:0030834
GeneOntologyBiologicalProcess	regulation of complement-dependent cytotoxicity	CFH CFHR4	3.42e-04	13	44	2	GO:1903659
GeneOntologyBiologicalProcess	actin filament depolymerization	FLII MYH9 VILL	3.77e-04	66	44	3	GO:0030042
GeneOntologyBiologicalProcess	complement-dependent cytotoxicity	CFH CFHR4	5.24e-04	16	44	2	GO:0097278
GeneOntologyBiologicalProcess	negative regulation of actin filament polymerization	FLII MYH9 VILL	5.49e-04	75	44	3	GO:0030837
GeneOntologyBiologicalProcess	retinal rod cell development	CFH CFHR4	5.93e-04	17	44	2	GO:0046548
GeneOntologyBiologicalProcess	glomerulus development	CFH NOTCH3 CFHR4	5.93e-04	77	44	3	GO:0032835
GeneOntologyBiologicalProcess	blood vessel development	CFH MYH9 ACVR1 MEGF8 TNFSF12 ADAMTS9 NOTCH3 CFHR4	6.87e-04	929	44	8	GO:0001568
GeneOntologyBiologicalProcess	angiogenesis	CFH MYH9 ACVR1 TNFSF12 ADAMTS9 NOTCH3 CFHR4	6.91e-04	708	44	7	GO:0001525
GeneOntologyBiologicalProcess	complement activation, alternative pathway	CFH CFHR4	7.43e-04	19	44	2	GO:0006957
GeneOntologyBiologicalProcess	leukocyte aggregation	CFH CFHR4	7.43e-04	19	44	2	GO:0070486
GeneOntologyBiologicalProcess	circulatory system development	CFH MYH9 ACVR1 PDLIM3 MEGF8 TNFSF12 ADAMTS9 VCAN NOTCH3 CFHR4	7.48e-04	1442	44	10	GO:0072359
GeneOntologyBiologicalProcess	regulation of innate immune response	CFH TRIM15 KAT5 TAX1BP1 CNOT7 CFHR4	7.73e-04	519	44	6	GO:0045088
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	FLII MYH9 VILL	9.05e-04	89	44	3	GO:1901880
GeneOntologyBiologicalProcess	vasculature development	CFH MYH9 ACVR1 MEGF8 TNFSF12 ADAMTS9 NOTCH3 CFHR4	9.05e-04	969	44	8	GO:0001944
GeneOntologyBiologicalProcess	negative regulation of protein polymerization	FLII MYH9 VILL	9.65e-04	91	44	3	GO:0032272
GeneOntologyBiologicalProcess	artery morphogenesis	MEGF8 ADAMTS9 NOTCH3	9.96e-04	92	44	3	GO:0048844
GeneOntologyCellularComponent	symbiont cell surface	CFH CFHR4	1.20e-04	8	44	2	GO:0106139
GeneOntologyCellularComponent	other organism part	CFH CFHR4	1.54e-04	9	44	2	GO:0044217
MousePheno	abnormal brain thrombosis	CFH NOTCH3 CFHR4	5.25e-08	4	34	3	MP:0031168
MousePheno	white pupil	CFH CFHR4	5.74e-06	2	34	2	MP:0006242
MousePheno	decreased serum complement activity	CFH CFHR4	5.74e-06	2	34	2	MP:0012553
MousePheno	artery occlusion	CFH CFHR4	5.74e-06	2	34	2	MP:0006134
MousePheno	decreased complement C5 level	CFH CFHR4	5.74e-06	2	34	2	MP:0012609
MousePheno	abnormal complement C5 level	CFH CFHR4	5.74e-06	2	34	2	MP:0012608
MousePheno	abnormal hepatic portal vein thrombosis	CFH CFHR4	5.74e-06	2	34	2	MP:0031159
MousePheno	hematuria	CFH MYH9 CFHR4	1.24e-05	19	34	3	MP:0005161
MousePheno	increased susceptilbility to retina ischemic injury	CFH CFHR4	1.72e-05	3	34	2	MP:0012049
MousePheno	abnormal kidney venous thrombosis	CFH CFHR4	1.72e-05	3	34	2	MP:0031161
MousePheno	abnormal response to retina ischemic injury	CFH CFHR4	3.43e-05	4	34	2	MP:0012048
MousePheno	increased susceptibility to type III hypersensitivity reaction	CFH CFHR4	3.43e-05	4	34	2	MP:0005615
MousePheno	decreased circulating complement protein level	CFH CFHR4	3.43e-05	4	34	2	MP:0020216
MousePheno	mesangial cell interposition	CFH CFHR4	3.43e-05	4	34	2	MP:0011512
MousePheno	increased creatine level	CFH CFHR4	3.43e-05	4	34	2	MP:0010061
MousePheno	impaired muscle relaxation	CFH CFHR4 SCN8A	4.13e-05	28	34	3	MP:0003157
MousePheno	abnormal venous thrombosis	CFH CFHR4	5.72e-05	5	34	2	MP:0031158
MousePheno	abnormal lung thrombosis	CFH CFHR4	5.72e-05	5	34	2	MP:0031167
MousePheno	abnormal circulating complement protein level	CFH CFHR4	8.56e-05	6	34	2	MP:0010215
MousePheno	abnormal glomerular capillary thrombosis	CFH CFHR4	1.20e-04	7	34	2	MP:0011508
MousePheno	brain ischemia	CFH CFHR4	1.59e-04	8	34	2	MP:0006080
MousePheno	abnormal complement protein level	CFH CFHR4	2.05e-04	9	34	2	MP:0011566
MousePheno	abnormal creatine level	CFH CFHR4	2.05e-04	9	34	2	MP:0010060
MousePheno	abnormal type III hypersensitivity reaction	CFH CFHR4	2.55e-04	10	34	2	MP:0002533
MousePheno	abnormal kidney thrombosis	CFH CFHR4	2.55e-04	10	34	2	MP:0011507
MousePheno	abnormal muscle relaxation	CFH CFHR4 SCN8A	4.30e-04	61	34	3	MP:0004036
MousePheno	abnormal visual acuity	CFH CFHR4	4.40e-04	13	34	2	MP:0011832
MousePheno	decreased visual acuity	CFH CFHR4	4.40e-04	13	34	2	MP:0006149
MousePheno	albuminuria	CFH MYH9 CFHR4	4.73e-04	63	34	3	MP:0002871
MousePheno	abnormal Bruch membrane morphology	CFH CFHR4	5.13e-04	14	34	2	MP:0005239
MousePheno	thin placenta labyrinth	MYH9 UBR4	5.13e-04	14	34	2	MP:0011523
MousePheno	abnormal visceral endoderm morphology	MYH9 ACVR1 ADAMTS9	5.42e-04	66	34	3	MP:0011186
MousePheno	retina detachment	CFH CFHR4	5.91e-04	15	34	2	MP:0003099
MousePheno	amyloid beta deposits	CFH CFHR4	7.63e-04	17	34	2	MP:0003329
MousePheno	abnormal gastrulation	MYH9 ACVR1 MEGF8 ADAMTS9 COPS5 VCAN	8.35e-04	469	34	6	MP:0001695
MousePheno	increased incidence of corneal inflammation	MYH9 PRMT3	8.57e-04	18	34	2	MP:0001313
MousePheno	hindlimb paralysis	CFH CFHR4 SCN8A	9.16e-04	79	34	3	MP:0000755
MousePheno	limb paralysis	CFH CFHR4 SCN8A	1.06e-03	83	34	3	MP:0013147
MousePheno	abnormal glomerular capillary endothelium morphology	CFH CFHR4	1.17e-03	21	34	2	MP:0011453
MousePheno	abnormal retina rod bipolar cell morphology	CFH CFHR4	1.41e-03	23	34	2	MP:0006074
MousePheno	abnormal embryo size	FLII MYH9 PRMT3 ACVR1 ADAMTS9 COPS5 VCAN UBR4	1.71e-03	956	34	8	MP:0001697
MousePheno	abnormal placental labyrinth vasculature morphology	KIFBP MYH9 UBR4	1.76e-03	99	34	3	MP:0008803
MousePheno	abnormal complement pathway	CFH CFHR4	1.80e-03	26	34	2	MP:0002471
MousePheno	impaired hearing	MYH9 NEK5 NOTCH3 SCN8A	2.01e-03	223	34	4	MP:0006325
MousePheno	abnormal thrombosis	CFH NOTCH3 CFHR4	2.14e-03	106	34	3	MP:0005048
MousePheno	enhanced wound healing	FLII VCAN	2.24e-03	29	34	2	MP:0002724
MousePheno	increased mesangial cell number	CFH CFHR4	2.24e-03	29	34	2	MP:0011427
MousePheno	decreased susceptibility to induction of seizure by inducing agent	GRIA3 SCN8A	2.24e-03	29	34	2	MP:0012348
MousePheno	abnormal vagus nerve morphology	KIFBP MEGF8	2.24e-03	29	34	2	MP:0001074
MousePheno	decreased susceptibility to pharmacologically induced seizures	GRIA3 SCN8A	2.24e-03	29	34	2	MP:0002887
MousePheno	abnormal developmental patterning	MYH9 ACVR1 MEGF8 ADAMTS9 COPS5 VCAN	2.41e-03	577	34	6	MP:0002084
MousePheno	disorganized embryonic tissue	ACVR1 ADAMTS9	2.55e-03	31	34	2	MP:0003988
Domain	Sushi	CFH PAMR1 VCAN CFHR4	6.08e-06	52	43	4	PF00084
Domain	CCP	CFH PAMR1 VCAN CFHR4	7.08e-06	54	43	4	SM00032
Domain	SUSHI	CFH PAMR1 VCAN CFHR4	8.20e-06	56	43	4	PS50923
Domain	Sushi_SCR_CCP_dom	CFH PAMR1 VCAN CFHR4	8.80e-06	57	43	4	IPR000436
Domain	Villin/Gelsolin	FLII VILL	1.44e-04	8	43	2	IPR007122
Domain	GEL	FLII VILL	1.44e-04	8	43	2	SM00262
Domain	EGF_CA	MEGF8 PAMR1 VCAN NOTCH3	1.76e-04	122	43	4	SM00179
Domain	EGF-like_Ca-bd_dom	MEGF8 PAMR1 VCAN NOTCH3	1.87e-04	124	43	4	IPR001881
Domain	Gelsolin	FLII VILL	4.63e-04	14	43	2	PF00626
Domain	Gelsolin-like_dom	FLII VILL	4.63e-04	14	43	2	IPR007123
Domain	ADF-H/Gelsolin-like_dom	FLII VILL	1.38e-03	24	43	2	IPR029006
Domain	-	FLII VILL	1.38e-03	24	43	2	3.40.20.10
Domain	EGF_Ca-bd_CS	MEGF8 VCAN NOTCH3	1.44e-03	97	43	3	IPR018097
Domain	EGF_CA	MEGF8 VCAN NOTCH3	1.53e-03	99	43	3	PS01187
Domain	ASX_HYDROXYL	MEGF8 VCAN NOTCH3	1.57e-03	100	43	3	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	MEGF8 VCAN NOTCH3	1.86e-03	106	43	3	IPR000152
Domain	EGF_3	MEGF8 PAMR1 VCAN NOTCH3	2.05e-03	235	43	4	PS50026
Domain	EGF	MEGF8 PAMR1 VCAN NOTCH3	2.05e-03	235	43	4	SM00181
Domain	EGF-like_dom	MEGF8 PAMR1 VCAN NOTCH3	2.53e-03	249	43	4	IPR000742
Domain	EGF_1	MEGF8 PAMR1 VCAN NOTCH3	2.76e-03	255	43	4	PS00022
Domain	EGF-like_CS	MEGF8 PAMR1 VCAN NOTCH3	3.00e-03	261	43	4	IPR013032
Domain	EGF	PAMR1 VCAN NOTCH3	3.04e-03	126	43	3	PF00008
Domain	EGF_2	MEGF8 PAMR1 VCAN NOTCH3	3.17e-03	265	43	4	PS01186
Domain	CUB	MEGF8 PAMR1	5.69e-03	49	43	2	PF00431
Domain	CUB	MEGF8 PAMR1	5.91e-03	50	43	2	SM00042
Domain	-	MEGF8 PAMR1	6.38e-03	52	43	2	2.60.120.290
Domain	CUB	MEGF8 PAMR1	6.62e-03	53	43	2	PS01180
Domain	CUB_dom	MEGF8 PAMR1	7.63e-03	57	43	2	IPR000859
Domain	Channel_four-helix_dom	KCNF1 SCN8A	7.63e-03	57	43	2	IPR027359
Domain	-	KCNF1 SCN8A	7.63e-03	57	43	2	1.20.120.350
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR	CFH CFHR4	6.53e-05	6	30	2	M47880
Pubmed	Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production.	CFH CFHR4	1.56e-06	2	44	2	31354740
Pubmed	Absence of complement factor H reduces physical performance in C57BL6 mice.	CFH CFHR4	1.56e-06	2	44	2	32962822
Pubmed	Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.	CFH CFHR4	1.56e-06	2	44	2	20538999
Pubmed	Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2.	CFH CFHR4	1.56e-06	2	44	2	4992636
Pubmed	Retinal changes precede visual dysfunction in the complement factor H knockout mouse.	CFH CFHR4	1.56e-06	2	44	2	23844226
Pubmed	Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b.	CFH CFHR4	1.56e-06	2	44	2	8615824
Pubmed	Cadmium Induces Glomerular Endothelial Cell-Specific Expression of Complement Factor H via the -1635 AP-1 Binding Site.	CFH CFHR4	1.56e-06	2	44	2	30642982
Pubmed	Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.	CFH CFHR4	1.56e-06	2	44	2	26374608
Pubmed	A gene locus concerned with an antigenic serum substance in Mus musculus.	CFH CFHR4	1.56e-06	2	44	2	4955525
Pubmed	Analysis of complement factor H mRNA expression: dexamethasone and IFN-gamma increase the level of H in L cells.	CFH CFHR4	1.56e-06	2	44	2	2533512
Pubmed	Complement factor H: spatial and temporal expression and localization in the eye.	CFH CFHR4	1.56e-06	2	44	2	16936129
Pubmed	Watching synchronous mitochondrial respiration in the retina and its instability in a mouse model of macular degeneration.	CFH CFHR4	1.56e-06	2	44	2	33558624
Pubmed	Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.	CFH CFHR4	1.56e-06	2	44	2	29398083
Pubmed	Complement factor H Y402H polymorphism results in diminishing CD4+ T cells and increasing C-reactive protein in plasma.	CFH CFHR4	1.56e-06	2	44	2	37940659
Pubmed	Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.	CFH CFHR4	1.56e-06	2	44	2	19620346
Pubmed	Complement factor H regulates retinal development and its absence may establish a footprint for age related macular degeneration.	CFH CFHR4	1.56e-06	2	44	2	30705315
Pubmed	A complement factor H homolog, heparan sulfation, and syndecan maintain inversin compartment boundaries in C. elegans cilia.	CFH CFHR4	1.56e-06	2	44	2	33859044
Pubmed	Regulation of age-related macular degeneration-like pathology by complement factor H.	CFH CFHR4	1.56e-06	2	44	2	25991857
Pubmed	Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.	CFH CFHR4	1.56e-06	2	44	2	29288229
Pubmed	Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.	CFH CFHR4	1.56e-06	2	44	2	33708358
Pubmed	Serological survey of complement factor H in common laboratory and wild mice: a new third allotype.	CFH CFHR4	1.56e-06	2	44	2	2522412
Pubmed	Absence of complement factor H alters bone architecture and dynamics.	CFH CFHR4	1.56e-06	2	44	2	30107932
Pubmed	Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.	CFH CFHR4	1.56e-06	2	44	2	34054871
Pubmed	Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo.	CFH CFHR4	1.56e-06	2	44	2	17562771
Pubmed	Aged complement factor H knockout mice kept in a clean barriered environment have reduced retinal pathology.	CFH CFHR4	1.56e-06	2	44	2	27397653
Pubmed	Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.	CFH CFHR4	1.56e-06	2	44	2	29392311
Pubmed	The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation.	CFH CFHR4	1.56e-06	2	44	2	22174452
Pubmed	Loss of Complement Factor H in Plasma Increases Endothelial Cell Migration.	CFH CFHR4	1.56e-06	2	44	2	28819420
Pubmed	Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids.	CFH CFHR4	1.56e-06	2	44	2	22875704
Pubmed	Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome.	KAT5 RCHY1	1.56e-06	2	44	2	14701804
Pubmed	Local complement factor H protects kidney endothelial cell structure and function.	CFH CFHR4	1.56e-06	2	44	2	34139209
Pubmed	Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model.	CFH CFHR4	1.56e-06	2	44	2	23799019
Pubmed	Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.	CFH CFHR4	1.56e-06	2	44	2	32849636
Pubmed	Complement factor h is critical in the maintenance of retinal perfusion.	CFH CFHR4	1.56e-06	2	44	2	19541934
Pubmed	Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.	CFH CFHR4	1.56e-06	2	44	2	17921253
Pubmed	The role of complement dysregulation in AMD mouse models.	CFH CFHR4	1.56e-06	2	44	2	24664701
Pubmed	Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light.	CFH CFHR4	1.56e-06	2	44	2	26149919
Pubmed	Murine protein H is comprised of 20 repeating units, 61 amino acids in length.	CFH CFHR4	1.56e-06	2	44	2	2940596
Pubmed	A receptor for the complement regulator factor H increases transmission of trypanosomes to tsetse flies.	CFH CFHR4	1.56e-06	2	44	2	32165615
Pubmed	Death by color: differential cone loss in the aging mouse retina.	CFH CFHR4	1.56e-06	2	44	2	24929970
Pubmed	Cfh genotype interacts with dietary glycemic index to modulate age-related macular degeneration-like features in mice.	CFH CFHR4	1.56e-06	2	44	2	24370827
Pubmed	Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.	CFH CFHR4	1.56e-06	2	44	2	23436934
Pubmed	Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model.	CFH CFHR4	1.56e-06	2	44	2	23469078
Pubmed	Topical cyclodextrin reduces amyloid beta and inflammation improving retinal function in ageing mice.	CFH CFHR4	1.56e-06	2	44	2	25921262
Pubmed	Complement factor h limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness.	CFH CFHR4	1.56e-06	2	44	2	15574507
Pubmed	Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.	CFH CFHR4	1.56e-06	2	44	2	23133374
Pubmed	Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.	CFH CFHR4	1.56e-06	2	44	2	30808757
Pubmed	Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury.	CFH CFHR4	1.56e-06	2	44	2	21544060
Pubmed	Role of ocular complement factor H in a murine model of choroidal neovascularization.	CFH CFHR4	1.56e-06	2	44	2	20813971
Pubmed	Location of the mouse complement factor H gene (cfh) by FISH analysis and replication R-banding.	CFH CFHR4	1.56e-06	2	44	2	1486806
Pubmed	A chimeric Cfh transgene leads to increased retinal oxidative stress, inflammation, and accumulation of activated subretinal microglia in mice.	CFH CFHR4	1.56e-06	2	44	2	26030099
Pubmed	Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.	CFH CFHR4	1.56e-06	2	44	2	17517971
Pubmed	Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.	CFH CFHR4	1.56e-06	2	44	2	20445496
Pubmed	Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits.	CFH CFHR4	1.56e-06	2	44	2	31133737
Pubmed	High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.	CFH CFHR4	1.56e-06	2	44	2	32737203
Pubmed	Distinct and separable roles of the complement system in factor H-deficient bone marrow chimeric mice with immune complex disease.	CFH CFHR4	1.56e-06	2	44	2	16597679
Pubmed	AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model.	CFH CFHR4	1.56e-06	2	44	2	37471073
Pubmed	Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease.	CFH CFHR4	1.56e-06	2	44	2	26802141
Pubmed	Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice.	CFH CFHR4	1.56e-06	2	44	2	25447048
Pubmed	Structure of the murine complement factor H gene.	CFH CFHR4	1.56e-06	2	44	2	2972715
Pubmed	Complement factor H deficiency combined with smoking promotes retinal degeneration in a novel mouse model.	CFH CFHR4	1.56e-06	2	44	2	34775843
Pubmed	p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.	FLII MYH9 PDLIM3	1.80e-06	19	44	3	16105984
Pubmed	Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.	CFH CFHR4	4.69e-06	3	44	2	12091909
Pubmed	Borrelia burgdorferi binding of host complement regulator factor H is not required for efficient mammalian infection.	CFH CFHR4	4.69e-06	3	44	2	17420242
Pubmed	Complement Regulatory Protein Factor H Is a Soluble Prion Receptor That Potentiates Peripheral Prion Pathogenesis.	CFH CFHR4	4.69e-06	3	44	2	29070671
Pubmed	Altered expression patterns of complement factor H and miR-146a genes in acute-chronic phases in experimental autoimmune encephalomyelitis mouse.	CFH CFHR4	4.69e-06	3	44	2	30972735
Pubmed	Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.	CFH CFHR4	4.69e-06	3	44	2	30025090
Pubmed	Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.	CFH CFHR4	4.69e-06	3	44	2	16023208
Pubmed	Location of theSas-1 locus on mouse chromosome 1.	CFH CFHR4	4.69e-06	3	44	2	21302086
Pubmed	Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.	CFH CFHR4	4.69e-06	3	44	2	23184055
Pubmed	DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells.	WNT5B NOTCH3	4.69e-06	3	44	2	37971882
Pubmed	Mesangial immune complex glomerulonephritis due to complement factor D deficiency.	CFH CFHR4	4.69e-06	3	44	2	17410102
Pubmed	C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.	CFH CFHR4	4.69e-06	3	44	2	32376801
Pubmed	VEGF regulates local inhibitory complement proteins in the eye and kidney.	CFH CFHR4	4.69e-06	3	44	2	27918307
Pubmed	Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes.	CFH CFHR4	4.69e-06	3	44	2	20702729
Pubmed	TRPV4 mediates the Ca2+ influx required for the interaction between flightless-1 and non-muscle myosin, and collagen remodeling.	FLII MYH9	4.69e-06	3	44	2	28526784
Pubmed	Changes in complement alternative pathway components, factor B and factor H during dengue virus infection in the AG129 mouse.	CFH CFHR4	4.69e-06	3	44	2	33410734
Pubmed	Complement factor H-deficient mice develop spontaneous hepatic tumors.	CFH CFHR4	4.69e-06	3	44	2	32369457
Pubmed	Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice.	CFH CFHR4	4.69e-06	3	44	2	16769899
Pubmed	Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration.	CFH CFHR4	4.69e-06	3	44	2	20181037
Pubmed	Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells.	CFH CFHR4	4.69e-06	3	44	2	19084272
Pubmed	Complement factor H deficiency accelerates development of lupus nephritis.	CFH CFHR4	4.69e-06	3	44	2	21148254
Pubmed	Complement factor H protects mice from ischemic acute kidney injury but is not critical for controlling complement activation by glomerular IgM.	CFH CFHR4	4.69e-06	3	44	2	29389016
Pubmed	Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.	CFH CFHR4	4.69e-06	3	44	2	29895552
Pubmed	Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.	CFH CFHR4	4.69e-06	3	44	2	19828624
Pubmed	Structural polymorphism of murine complement factor H controlled by a locus located between the Hc and the beta 2M locus on the second chromosome of the mouse.	CFH CFHR4	4.69e-06	3	44	2	3156187
Pubmed	Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model.	CFH CFHR4	4.69e-06	3	44	2	20854881
Pubmed	Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.	CFH CFHR4	4.69e-06	3	44	2	31409673
Pubmed	Two factor H-related proteins from the mouse: expression analysis and functional characterization.	CFH CFHR4	4.69e-06	3	44	2	17028856
Pubmed	Localization of complement factor H gene expression and protein distribution in the mouse outer retina.	CFH CFHR4	4.69e-06	3	44	2	25684976
Pubmed	Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.	CFH CFHR4	4.69e-06	3	44	2	18202746
Pubmed	Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia.	CFH CFHR4	4.69e-06	3	44	2	29858280
Pubmed	Complement component C3 plays a critical role in protecting the aging retina in a murine model of age-related macular degeneration.	CFH CFHR4	4.69e-06	3	44	2	23747511
Pubmed	Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes.	CFH CFHR4	4.69e-06	3	44	2	26768663
Pubmed	Interleukin 27 induces the expression of complement factor H (CFH) in the retina.	CFH CFHR4	4.69e-06	3	44	2	23029250
Pubmed	The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.	CFH CFHR4	9.37e-06	4	44	2	22832515
Pubmed	Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.	CFH CFHR4	9.37e-06	4	44	2	27165610
Pubmed	Genetic polymorphism of microsomal epoxide hydrolase activity in the mouse.	CFH CFHR4	9.37e-06	4	44	2	7410386
Pubmed	CD11b is protective in complement-mediated immune complex glomerulonephritis.	CFH CFHR4	9.37e-06	4	44	2	25565310
Pubmed	A2E accumulation influences retinal microglial activation and complement regulation.	CFH CFHR4	9.37e-06	4	44	2	22819137
Cytoband	1q32	CFH CFHR4	1.03e-03	49	44	2	1q32
Cytoband	Ensembl 112 genes in cytogenetic band chr1q31	CFH CFHR4	2.38e-03	75	44	2	chr1q31
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFH PAMR1 VCAN CFHR4	3.84e-06	57	34	4	1179
GeneFamily	Gelsolin/villins	FLII VILL	9.54e-05	8	34	2	950
GeneFamily	Complement system\|Sushi domain containing	CFH CFHR4	2.08e-03	36	34	2	492
Coexpression	TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL	CFH PDLIM3 PAMR1 VCAN	4.34e-06	65	44	4	M41673
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000	PDLIM3 PAMR1 VILL ADAMTS9 VCAN NOTCH3	2.98e-05	293	44	6	gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIFBP TNFSF12 RCHY1 NOTCH3 THAP7	1.09e-06	186	44	5	ed9b1a784f67e8a297e2a10993a6d97df60581ac
ToppCell	ASK428-Mesenchymal\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	CFH PDLIM3 PAMR1 VCAN NOTCH3	1.38e-06	195	44	5	2b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell	ASK428-Mesenchymal-Fibroblast\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	CFH PDLIM3 PAMR1 VCAN NOTCH3	1.38e-06	195	44	5	c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH GRIA3 PDLIM3 PAMR1 VCAN	1.52e-06	199	44	5	1f20addc0d138fec02ed6ca4c518169c568de263
ToppCell	distal-mesenchymal-Myofibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH GRIA3 PDLIM3 PAMR1 VCAN	1.56e-06	200	44	5	069c8949b33ecfdb6da32992002d4060ff6082bc
ToppCell	distal-mesenchymal-Myofibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH GRIA3 PDLIM3 PAMR1 VCAN	1.56e-06	200	44	5	61854a459385cd9295be37157a8f81a2c227dff3
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH GRIA3 VCAN CFHR4	2.32e-05	169	44	4	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	2.43e-05	171	44	4	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Airway_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SERTAD4 CFH PDLIM3 JMJD7	2.54e-05	173	44	4	b23b408acc29a667cce104429afef1a6cf2720a5
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	2.78e-05	177	44	4	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	2.78e-05	177	44	4	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.03e-05	181	44	4	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH WNT5B PDLIM3 VCAN	3.03e-05	181	44	4	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.03e-05	181	44	4	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH WNT5B PDLIM3 VCAN	3.03e-05	181	44	4	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFH WNT5B KAT5 VCAN	3.17e-05	183	44	4	07ca2786e62eca9feecf5e54a11864a960f7641a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.17e-05	183	44	4	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SERTAD4 CFH PAMR1 VCAN	3.23e-05	184	44	4	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SERTAD4 CFH PDLIM3 KCNF1	3.30e-05	185	44	4	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH9 PDLIM3 ADAMTS9 VCAN	3.30e-05	185	44	4	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH PDLIM3 PAMR1 VCAN	3.37e-05	186	44	4	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SERTAD4 CFH PDLIM3 KCNF1	3.44e-05	187	44	4	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CFH WNT5B NOTCH3 FAM149A	3.44e-05	187	44	4	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	CFH SLC28A3 PDLIM3 ADAMTS9	3.59e-05	189	44	4	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRIA3 PDLIM3 PAMR1 NOTCH3	3.59e-05	189	44	4	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFH WNT5B PAMR1 VCAN	3.67e-05	190	44	4	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	CFH PDLIM3 ADAMTS9 NOTCH3	3.74e-05	191	44	4	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	(5)_Epi_basal\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	SERTAD4 CFH PDLIM3 ADAMTS9	3.74e-05	191	44	4	6bda3d5a8a391d41bb4d65872492e6c094bcc4d4
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CFH WNT5B PDLIM3 PAMR1	3.82e-05	192	44	4	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	CFH WNT5B PDLIM3 PAMR1	3.82e-05	192	44	4	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	3.90e-05	193	44	4	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	3.90e-05	193	44	4	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.98e-05	194	44	4	91205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	3.98e-05	194	44	4	29f83cdd63314fff41258937d70b881a5503bfcc
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH PAMR1 TNFSF12 VCAN	3.98e-05	194	44	4	3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.98e-05	194	44	4	8fae8061b350336299aa81f378e07deadbd55123
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5B SLC28A3 PDLIM3 NOTCH3	3.98e-05	194	44	4	0ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	3.98e-05	194	44	4	d3db241ea316bbcde6d16618193b474591ad5ce4
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH SLC28A3 PDLIM3 ADAMTS9	3.98e-05	194	44	4	421344cc4b601d9745fa72d0af3124dab11d1d27
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.98e-05	194	44	4	4d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.98e-05	194	44	4	6e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell	3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	3.98e-05	194	44	4	c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFH PAMR1 TNFSF12 VCAN	3.98e-05	194	44	4	ff19fb5bc7feae3e774ef4ab720beb9dec219f45
ToppCell	18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high\|Distal / Age, Tissue, Lineage and Cell class	SERTAD4 CFH PDLIM3 PAMR1	4.06e-05	195	44	4	f86737bff21d81673238813df61a15cfe88d0b15
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNT5B SLC28A3 VILL NOTCH3	4.06e-05	195	44	4	25703e3c2e0512ef12e7aa389fad3968c3f13905
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERTAD4 CFH TNFSF12 VCAN	4.06e-05	195	44	4	690d6e15d7c863fc8f2d33b1f7bf86f019f415c9
ToppCell	facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERTAD4 CFH TNFSF12 VCAN	4.06e-05	195	44	4	5c05e2bcea3d5d7ebe6325f7187ccf83301053d8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH GRIA3 PDLIM3 PAMR1	4.22e-05	197	44	4	16758f181ef07c60aee63072e1da9572c5c85414
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDLIM3 ADAMTS9 NOTCH3	4.22e-05	197	44	4	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.22e-05	197	44	4	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PDLIM3 PAMR1 VCAN	4.22e-05	197	44	4	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.22e-05	197	44	4	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.22e-05	197	44	4	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDLIM3 ADAMTS9 NOTCH3	4.30e-05	198	44	4	dc6d9032c5029527e184ac13b887c0c1f22ef1c0
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SERTAD4 CFH PDLIM3 PAMR1	4.30e-05	198	44	4	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	distal-mesenchymal-Myofibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH PDLIM3 PAMR1 VCAN	4.30e-05	198	44	4	beef5075ba6dcd4d0a447bc4e57efcaf2e93c546
ToppCell	Sepsis-URO-Lymphocyte-T/NK-MAIT\|URO / Disease, condition lineage and cell class	CFH IL18R1 DNAH14 SCN8A	4.30e-05	198	44	4	75db638278d4be2b0f406cd8871058a8352c5a86
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.39e-05	199	44	4	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	distal-2-mesenchymal-Myofibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CFH GRIA3 PDLIM3 PAMR1	4.39e-05	199	44	4	b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.39e-05	199	44	4	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CFH ADAMTS9 VCAN NOTCH3	4.39e-05	199	44	4	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH9 PDLIM3 ADAMTS9 NOTCH3	4.48e-05	200	44	4	2bc7f462a551292de2501028164573935232f899
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDLIM3 ADAMTS9 NOTCH3	4.48e-05	200	44	4	38190e4b32f7469df1da7d130bca6d7b12a3dd06
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH WNT5B SLC28A3 NOTCH3	4.48e-05	200	44	4	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CFH GRIA3 PDLIM3 PAMR1	4.48e-05	200	44	4	b441b3771fb7d9ee7b7a104afc35e466aace2da2
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	GRIA3 PDLIM3 PAMR1 VCAN	4.48e-05	200	44	4	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH PDLIM3 PAMR1 VCAN	4.48e-05	200	44	4	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	PDLIM3 PAMR1 VCAN NOTCH3	4.48e-05	200	44	4	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CFH PDLIM3 PAMR1 ADAMTS9	4.48e-05	200	44	4	c082bc21ec7c5323439d108ea8aea510e1113c3f
ToppCell	Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CFH GRIA3 PDLIM3 PAMR1	4.48e-05	200	44	4	0aa316b71f195ecf17ee897e307f8928a755a637
ToppCell	390C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYH9 PDLIM3 ADAMTS9 NOTCH3	4.48e-05	200	44	4	8b80a65b69b36ed405214564b939452c90aa40d6
ToppCell	Thalamus-Endothelial-MURAL-M1(Rgs5Acta2)\|Thalamus / BrainAtlas - Mouse McCarroll V32	WNT5B PDLIM3 NOTCH3	2.61e-04	126	44	3	333f83f9ba64d46f22fee328d0a691fd5818bdac
ToppCell	Thalamus-Endothelial-MURAL\|Thalamus / BrainAtlas - Mouse McCarroll V32	WNT5B PDLIM3 NOTCH3	2.61e-04	126	44	3	cf571f36761da3540fb445de89d555cbce8a47ab
ToppCell	AT1-AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	AATK PDLIM3 ADAMTS9	3.56e-04	140	44	3	45d52a086ced8d58e01ac51ac4a90338e8649b16
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 VILL KCNF1	4.18e-04	148	44	3	f58804d24fe524b42b5090c8658050ea4b14793e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CABP7\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFH ADAMTS9 CFHR4	5.06e-04	158	44	3	3fb5a5701a39824f7f23748709a3e0e1db551269
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 VILL KCNF1	5.16e-04	159	44	3	c9e093d7c1dca83f6546adaf3d874929e2cea612
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACVR1 IL18R1 VCAN	5.25e-04	160	44	3	6215ac6123a295f3c2f033786602a57b2e2e1177
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	PDLIM3 ADAMTS9 NOTCH3	5.25e-04	160	44	3	fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDLIM3 PAMR1 VCAN	5.25e-04	160	44	3	8624f101828efd32cdd38a65df8d94d690720a63
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDLIM3 PAMR1 VCAN	5.25e-04	160	44	3	9de3dd6b9d4b51314d60b3b01f4132bcfa2dfc18
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	PDLIM3 ADAMTS9 NOTCH3	5.35e-04	161	44	3	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PAMR1 VILL KCNF1	5.35e-04	161	44	3	66554f59eaea4ba55a6c6724f9368e24e99c91e9
ToppCell	droplet-Marrow-BM-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TESMIN TNFSF12 UBR4	5.45e-04	162	44	3	75df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_LINC00507_SLN\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDLIM3 PAMR1 ADAMTS9	5.45e-04	162	44	3	b59a0081e285cdf33de56e8b523fe0e446a198f1
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH WNT5B AATK	5.54e-04	163	44	3	1feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDLIM3 IL18R1 NOTCH3	5.54e-04	163	44	3	1c014e373667be290d7fb5d24c06c6f313ac8fa3
ToppCell	URO-Lymphocyte-T_NK-MAIT\|URO / Disease, Lineage and Cell Type	CFH IL18R1 SCN8A	5.64e-04	164	44	3	cb42a70433b3968caca67f7aa98ea536cd90a0bc
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	IL18R1 VCAN SCN8A	5.85e-04	166	44	3	65dafed953b01a9830b54309af75c7a561e88336
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	CFH PAMR1 ADAMTS9	5.85e-04	166	44	3	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH GRIA3 PDLIM3	5.95e-04	167	44	3	a4a795751644b22af616335379e64ae95175180c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH PAMR1 VCAN	6.05e-04	168	44	3	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CFH TNFSF12 ADAMTS9	6.05e-04	168	44	3	9930bd63b60c03f0152838a79eef77da1c2dd8e5
ToppCell	Posterior_cortex-Endothelial-MURAL\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	WNT5B PDLIM3 NOTCH3	6.16e-04	169	44	3	0ae65daf092396b71f790b65c7a2feed90397417
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	WNT5B PDLIM3 NOTCH3	6.16e-04	169	44	3	8cd70ce27b1cecb83f8a376230e7ef41b079b124
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDLIM3 KCNF1 VCAN	6.16e-04	169	44	3	1c9e54e7b14eb99996590fb93b257cf881a9f184
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	CFH VILL VCAN	6.16e-04	169	44	3	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	Frontal_cortex-Macroglia-POLYDENDROCYTE\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NEK5 COPS5 ATXN7L3B	6.16e-04	169	44	3	50cc0f5a022b95986949db63208a627cef9f4a69
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	TRIM15 NEK5 FAM149A	6.26e-04	170	44	3	d682178d11d67eb5a02d0c6b3967645e37bcc62a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNFSF12 IL18R1 NOTCH3	6.26e-04	170	44	3	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
Disease	c3d:C3 ratio	CFH CFHR4	2.07e-06	2	43	2	EFO_0008543
Disease	calnexin measurement	CFH CFHR4	6.22e-06	3	43	2	EFO_0801444
Disease	complement factor H-related protein 4A measurement	CFH CFHR4	6.22e-06	3	43	2	EFO_0600057
Disease	histone-lysine N-methyltransferase 2D measurement	CFH CFHR4	6.22e-06	3	43	2	EFO_0801683
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFH CFHR4	1.24e-05	4	43	2	EFO_0803292
Disease	kallikrein-5 measurement	CFH CFHR4	1.24e-05	4	43	2	EFO_0020515
Disease	tumor necrosis factor ligand superfamily member 12 measurement	CFH TNFSF12	3.10e-05	6	43	2	EFO_0010801
Disease	complement C1s subcomponent measurement	CFH CFHR4	3.10e-05	6	43	2	EFO_0008091
Disease	cytoskeleton-associated protein 2 measurement	CFH MYH9	5.78e-05	8	43	2	EFO_0020309
Disease	Atypical hemolytic-uremic syndrome	CFH CFHR4	7.42e-05	9	43	2	cv:C2931788
Disease	Hemolytic-uremic syndrome	CFH CFHR4	7.42e-05	9	43	2	cv:C0019061
Disease	leukocyte immunoglobulin-like receptor subfamily A member 5 measurement	CFH CFHR4	7.42e-05	9	43	2	EFO_0801766
Disease	hemopexin measurement	CFH CFHR4	1.13e-04	11	43	2	EFO_0008149
Disease	obesity (implicated_via_orthology)	FLII KAT5 ADAMTS9 NOTCH3	2.71e-04	215	43	4	DOID:9970 (implicated_via_orthology)
Disease	coagulation factor measurement	CFH CFHR4	3.88e-04	20	43	2	EFO_0004634
Disease	complement factor H-related protein 2 measurement	CFH CFHR4	8.21e-04	29	43	2	EFO_0600055
Disease	Age related macular degeneration	CFH CFHR4	8.79e-04	30	43	2	C0242383
Disease	Complement deficiency disease	CFH CFHR4	1.06e-03	33	43	2	C0272242

Protein segments in the cluster

Peptide	Gene	Start	Entry
TLKSGHYICDAYDFE	USP26	836	Q9BXU7
IEDFGVHCKQYYALE	COPS5	211	Q92905
VYCYVDHLDGDVFHL	VCAN	241	P13611
EVHRAVKCGYFYLEF	ATXN7L3B	36	Q96GX2
DGFHVYQKGCFQVYE	ACVR1	61	Q04771
KEEYGHSEVVEYYCN	CFH	646	P08603
ECGYKYRFFGEDAEI	MSH3	251	P20585
EFEDQGYYSCVHFLH	IL18R1	176	Q13478
EAFHGKFYEADCYIV	FLII	516	Q13045
VYHVDGKIEEYFAFD	FAM149A	401	A5PLN7
HYENLYCVVSGEKHF	JMJD7	181	P0C870
YEEAGSDFHQVAYFK	KIAA1109	3226	Q2LD37
FLFYVMTEYDCKGFH	KAT5	336	Q92993
MTEYDCKGFHIVGYF	KAT5	341	Q92993
YEGYCVDLAYEIAKH	GRIA3	451	P42263
FKEYECVKEHGDYTD	NEK5	616	Q6P3R8
YEKYCADHFADGRCD	NOTCH3	1471	Q9UM47
YQEEKCYEDGIFFYH	MEGF8	471	Q7Z7M0
VKDHYIFYCEGELHG	LCN1	111	P31025
ADFCIIHYAGKVDYK	MYH9	566	P35579
FEDHIDDAKYCGHLY	CNOT7	246	Q9UIV1
SEEEAELKHCFYKGY	ADAMTS9	141	Q9P2N4
IAGYFDIYFEKNCHN	PRMT3	451	O60678
FKLHDTLDYECYDGY	CFHR4	166	Q92496
EHVQDIFYGHCVDKY	DNAH14	3001	Q0VDD8
HEECVFPFTYKGSVY	ELSPBP1	26	Q96BH3
YEKSCVFPYDLYHAE	HELB	346	Q8NG08
HYVFEAKEFFQIDGY	KIFBP	401	Q96EK5
GTLDDFYVKGFYCAE	PAMR1	101	Q6UXH9
YEEDEFHVFKEAYLG	TESMIN	41	Q9Y4I5
DGEFYQFCYVTHKGE	TAX1BP1	96	Q86VP1
DYGLAHCKYREDYFV	AATK	271	Q6ZMQ8
GYFFIEGELYCETHA	PDLIM3	331	Q53GG5
IGYKTFFNEFVAYEH	SLC28A3	511	Q9HAS3
LAFECKGQFYDYFET	SERTAD4	306	Q9NUC0
PASEYIYFCSKHFEE	THAP7	56	Q9BT49
YYALGGHKDAIVACF	PWP2	181	Q15269
TYCEEHGEKIYFFCE	TRIM15	81	Q9C019
CGDNVEYGYRFAKEF	WNT5B	161	Q9H1J7
GKYHYCFNETSEIRF	SCN8A	1351	Q9UQD0
AYGNFFEEHCYVILH	VILL	31	O15195
HCDIYVKVFYAFSNA	ZNF429	146	Q86V71
YYLYCQVHFDEGKAV	TNFSF12	161	O43508
LFGEYYCDICHLFDK	RCHY1	81	Q96PM5
DHEISYAKYGSFFCD	UBR4	1701	Q5T4S7
FKCVIEVYYFGEVHM	KCNF1	86	Q9H3M0